对接受免疫治疗的癌症患者进行基准不匹配修复测试
Elias Bou Farhat1, Elio Adib1, Melissa Daou1
1Brigham and Women's Hospital, Boston, MA, USA.
Cancer cell
|December 29, 2023
概括
对不匹配修复 (MMR) 突变特征的下一代测序为检测MMR缺陷 (MMD) 提供了比免疫组织化学 (IHC) 更高的灵敏度. 这种先进的测试可以识别IMC错过的MMR-D病例,确保对结直肠和子宫内膜癌更准确的诊断.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子诊断学 分子诊断
背景情况:
- 免疫组织化学 (IHC) 是用于识别不匹配修复缺陷 (MMR-D) 的标准初始诊断测试.
- 然而,IHC可能无法检测到MMR-D的所有病例,这可能导致诊断不足.
- 准确的MMR-D检测对于指导治疗决策和预测患者结果至关重要.
研究的目的:
- 使用下一代测序 (NGS) 评估不匹配修复 (MMR) 突变特征分析的灵敏度.
- 将基于NGS的MMR突变特征的诊断性能与用于检测MMR-D的IHC进行比较.
- 评估NGS发现但IHC遗漏的MMR-D瘤患者的临床结果.
主要方法:
- 利用基于下一代测序 (NGS) 的试验来确定MMR突变特征.
- 将NGS测定结果与MMR蛋白表达标准免疫组织化学 (IHC) 的结果进行了比较.
- 分析了MMR-D瘤患者的临床结果,包括治疗反应和生存率.
主要成果:
- MMR突变特征测定在检测MMR-D时表现出高灵敏度.
- 在1%的结直肠癌 (CRC) 患者和5%的子宫内膜癌 (EC) 患者中,NGS发现了IMC错过的MMR-D病例.
- 由IHC遗漏的MMR-D瘤患者的临床结果与IHC和NGS签名检测到的MMR-D患者相似.
结论:
- 基于NGS的MMR突变特征分析是检测MMR缺陷的高度敏感方法.
- 这种测试可以识别常规IHC测试遗漏的MMR-D病例.
- 这些发现表明,NGS为MMR-D诊断提供了更全面的方法,可能会影响患者管理和结果.
相关概念视频
01:27Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
01:20Mismatch Repair
4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K